IL299301A - Compositions and methods for the treatment of obsessive compulsive disorder - Google Patents
Compositions and methods for the treatment of obsessive compulsive disorderInfo
- Publication number
- IL299301A IL299301A IL299301A IL29930122A IL299301A IL 299301 A IL299301 A IL 299301A IL 299301 A IL299301 A IL 299301A IL 29930122 A IL29930122 A IL 29930122A IL 299301 A IL299301 A IL 299301A
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- methods
- compulsive disorder
- treating obsessive
- obsessive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063043681P | 2020-06-24 | 2020-06-24 | |
| PCT/US2021/038789 WO2021262914A1 (en) | 2020-06-24 | 2021-06-24 | Compositions and methods for treating obsessive-compulsive disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL299301A true IL299301A (en) | 2023-02-01 |
Family
ID=79281806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL299301A IL299301A (en) | 2020-06-24 | 2021-06-24 | Compositions and methods for the treatment of obsessive compulsive disorder |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230181541A1 (https=) |
| EP (1) | EP4171554A4 (https=) |
| JP (1) | JP7805969B2 (https=) |
| KR (1) | KR20230027189A (https=) |
| CN (1) | CN115968312A (https=) |
| AU (1) | AU2021297249A1 (https=) |
| BR (1) | BR112022025901A2 (https=) |
| CA (1) | CA3187323A1 (https=) |
| IL (1) | IL299301A (https=) |
| MX (1) | MX2022016174A (https=) |
| PH (1) | PH12022553441A1 (https=) |
| WO (1) | WO2021262914A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP2400349A1 (hu) * | 2024-07-05 | 2026-01-28 | Egis Gyógyszergyár Zrt. | Troriluzole-hidroklorid-sók |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2564187T3 (es) * | 2005-04-05 | 2016-03-18 | Yale University | Agentes de modulación de glutamato en el tratamiento de trastornos mentales |
| WO2016140879A1 (en) * | 2015-03-03 | 2016-09-09 | Biohaven Pharmaceutical Holding Company Ltd. | Riluzole prodrugs and their use |
| JP2018521007A (ja) * | 2015-05-22 | 2018-08-02 | ヴィスタゲン セラピューティクス、インコーポレイテッド | Ｌ−４−クロロキヌレニンの治療的使用 |
| TW202000205A (zh) * | 2018-02-21 | 2020-01-01 | 美商Ａｉ治療公司 | 使用阿吡莫德與麩胺酸性劑的組合治療 |
| MX2020012377A (es) * | 2018-05-27 | 2021-04-12 | Biohaven Therapeutics Ltd | Uso de tabletas de desintegracion orales de riluzol para el tratamiento de enfermedades. |
| MX2021000515A (es) * | 2018-07-22 | 2021-06-08 | Biohaven Therapeutics Ltd | Uso de profarmacos de riluzol para tratar enfermedad de alzheimer. |
| US20210315865A1 (en) * | 2018-08-16 | 2021-10-14 | Biohaven Therapeutics Ltd. | Use of riluzole oral disintigrating tablets for treating diseases |
-
2021
- 2021-06-24 JP JP2022578616A patent/JP7805969B2/ja active Active
- 2021-06-24 PH PH1/2022/553441A patent/PH12022553441A1/en unknown
- 2021-06-24 MX MX2022016174A patent/MX2022016174A/es unknown
- 2021-06-24 BR BR112022025901A patent/BR112022025901A2/pt unknown
- 2021-06-24 US US17/923,587 patent/US20230181541A1/en active Pending
- 2021-06-24 KR KR1020237001813A patent/KR20230027189A/ko active Pending
- 2021-06-24 AU AU2021297249A patent/AU2021297249A1/en active Pending
- 2021-06-24 CA CA3187323A patent/CA3187323A1/en active Pending
- 2021-06-24 EP EP21829058.3A patent/EP4171554A4/en active Pending
- 2021-06-24 CN CN202180044180.1A patent/CN115968312A/zh active Pending
- 2021-06-24 IL IL299301A patent/IL299301A/en unknown
- 2021-06-24 WO PCT/US2021/038789 patent/WO2021262914A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2021297249A1 (en) | 2023-02-23 |
| BR112022025901A2 (pt) | 2023-01-10 |
| WO2021262914A1 (en) | 2021-12-30 |
| EP4171554A1 (en) | 2023-05-03 |
| US20230181541A1 (en) | 2023-06-15 |
| PH12022553441A1 (en) | 2024-03-04 |
| MX2022016174A (es) | 2023-01-24 |
| CA3187323A1 (en) | 2021-12-30 |
| CN115968312A (zh) | 2023-04-14 |
| KR20230027189A (ko) | 2023-02-27 |
| JP2023531919A (ja) | 2023-07-26 |
| JP7805969B2 (ja) | 2026-01-26 |
| EP4171554A4 (en) | 2024-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202207394B (en) | Compositions and methods for treating hemoglobinopathies | |
| IL309296A (en) | Methods and compositions for the treatment of angiotensinogen-related disorder (AGT-) | |
| IL286350A (en) | Preparations and methods for the treatment of cancer | |
| IL288914A (en) | Preparations and methods for the treatment of cancer | |
| SG11202011080QA (en) | Methods and compositions for treating cancer | |
| ZA202104870B (en) | Methods and compositions for treating cancer | |
| GB2578539B (en) | Compositions and methods for preventing or treating muscle conditions | |
| IL285886A (en) | Preparations and methods for the treatment of laminopathy | |
| IL285796A (en) | Methods and preparations for the treatment of cancer | |
| PT3807316T (pt) | Composições e métodos para tratamento de cancro | |
| IL287982A (en) | Preparations and methods for the treatment of cancer | |
| EP3976187A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF EPILEPSY | |
| SG11202012055PA (en) | Methods and compositions for preventing or treating calciphylaxis | |
| IL299295A (en) | Methods and compositions for treating hemophilia | |
| IL305806A (en) | Compounds and methods for the treatment of polycythemia | |
| IL286153A (en) | Methods and preparations for the treatment of cancer | |
| IL309120A (en) | Methods and compositions for the treatment of cancer | |
| IL309071A (en) | Methods and compositions for the treatment of cancer | |
| IL299301A (en) | Compositions and methods for the treatment of obsessive compulsive disorder | |
| EP4251161A4 (en) | TREATMENT OF OCD WITH BOL-148 | |
| SG11202107355RA (en) | Improved method and compositions for surface treatment | |
| IL312846A (en) | Methods and preparations for the treatment of cancer | |
| IL289795A (en) | Compositions and methods for treating vasoconstriction in the brain | |
| HK40085044A (en) | Compositions and methods for treating obsessive-compulsive disorder | |
| IL285036A (en) | Methods and preparations for the treatment of cancer |